Scarica l'app Stockscreener
3.0513
0.97%
-0.0487
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SANA Giù?
Forum
Previsione
Sana Biotechnology Inc Borsa (SANA) Ultime notizie
Sana Biotechnology (NASDAQ:SANA) Trading Down 7.2%Here's What Happened - MarketBeat
Shorts Report: How does Sana Biotechnology Inc score in quality rankingsMarket Sentiment Review & Accurate Intraday Trade Tips - baoquankhu1.vn
Sana Biotechnology, Inc. (NASDAQ:SANA) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Sana Biotechnology (SANA) appoints industry veteran Brian Piper as new CFO - MSN
SANA Forecast, Price Target & Analyst Ratings | SANA BIOTECHNOLOGY INC (NASDAQ:SANA) - ChartMill
Bull Run: Will Sana Biotechnology Inc stock hit new highs in YEAR2026 Outlook & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Breakouts Watch: Can Sana Biotechnology Inc be the next market leaderDay Trade & High Accuracy Buy Signal Tips - baoquankhu1.vn
H.C. Wainwright reiterates Sana Biotechnology stock buy rating - Investing.com
Sana Biotechnology reports 14-month data on diabetes cell therapy By Investing.com - Investing.com India
Integral Health Asset Management LLC Has $7.10 Million Stock Position in Sana Biotechnology, Inc. $SANA - MarketBeat
Morgan Stanley Maintains Overweight on Sana Biotechnology, Inc. (SANA) March 2026 - Meyka
Morgan Stanley reiterates Sana Biotechnology stock rating on diabetes data By Investing.com - Investing.com Canada
Sana Biotechnology (NASDAQ:SANA) Trading Up 7.8%Here's What Happened - MarketBeat
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression - Bitget
Sana Biotechnology reports 14-month data on diabetes cell therapy - Investing.com
Analysts Offer Insights on Healthcare Companies: Sana Biotechnology (SANA) and Rapport Therapeutics, Inc. (RAPP) - The Globe and Mail
Earnings Report: Will Sana Biotechnology Inc benefit from sector rotation2026 Earnings Surprises & Consistent Return Investment Signals - baoquankhu1.vn
SANA: Hypoimmune and in vivo CAR T platforms advance toward clinical trials, with key data expected soon - TradingView
Sana (SANA) CEO Steve Harr vests RSUs and uses 24,345 shares for tax - Stock Titan
Sana Biotechnology (SANA) officer exercises RSUs and withholds shares for taxes - Stock Titan
VIX Spike: Can Sana Biotechnology Inc be the next market leader2026 Chart Watch & Comprehensive Market Scan Reports - baoquankhu1.vn
Sana Biotechnology (SANA) Expected to Announce Quarterly Earnings on Monday - MarketBeat
Sana Diabetes Data And Funding Moves Reframe Risk For NasdaqGS SANA Investors - Sahm
SANA Should I Buy - Intellectia AI
Aug Drivers: Is Sana Biotechnology Inc attractive at current valuation2025 Market Trends & Short-Term High Return Ideas - baoquankhu1.vn
Sana Biotechnology (SANA) CEO granted 200,000 RSUs and 900,000 stock options - Stock Titan
TD Cowen reiterates Buy rating on Sana Biotechnology stock By Investing.com - Investing.com Canada
TD Cowen reiterates Buy rating on Sana Biotechnology stock - Investing.com UK
Q1 EPS Estimate for Sana Biotechnology Lowered by Analyst - MarketBeat
Sana Biotechnology (NASDAQ:SANA) Stock Price Down 9.7% After Analyst Downgrade - MarketBeat
What is HC Wainwright's Forecast for SANA FY2030 Earnings? - MarketBeat
Seattle InnoCajal raises $96M I Layoffs at Sana - The Business Journals
Sana Biotechnology (NASDAQ:SANA) Cut to Hold at Zacks Research - MarketBeat
Citizens reiterates Sana Biotechnology stock rating on pipeline progress By Investing.com - Investing.com Nigeria
AI Adoption Exposes Sana Biotechnology to Rising Data, Compliance, and Reputational Risks - TipRanks
Sana Biotechnology (SANA) officer exercises RSUs, uses 491 shares for taxes - Stock Titan
Sana Biotechnology Diabetes Data And CAR T Plans Shape Pipeline Outlook - simplywall.st
Sana Biotechnology (SANA) Q4 2025 Financial Results: Net Loss and Analyst OutlookNews and Statistics - IndexBox
Sana Biotechnology (NASDAQ:SANA) Price Target Lowered to $7.00 at HC Wainwright - MarketBeat
Sana Biotech's Q4 Net Loss Expands; Plans To Submit IND For SC451 In 2026; Stock Down - Nasdaq
Sana Biotechnology files for mixed shelf size not disclosedSEC filing - marketscreener.com
Sana Biotechnology Files For Mixed Shelf Size Not DisclosedSEC Filing - TradingView
Sana Biotechnology (NASDAQ: SANA) files ATM to raise up to $150M with TD Cowen - Stock Titan
Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates - Bitget
Sana: Overview of Fourth Quarter Financial Results - Bitget
Sana Biotechnology Updates ATM Program to Support Development - TipRanks
Earnings Flash (SANA) Sana Biotechnology, Inc. Posts Q4 Adjusted Loss $0.16 per Share, vs. FactSet Est of $-0.14 - marketscreener.com
Going concern risk and focused pipeline at Sana Biotechnology (NASDAQ: SANA) - Stock Titan
Sana Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Sana Biotechnology (NASDAQ: SANA) sets $150.0 million ATM program - Stock Titan
SANA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Sana Biotechnology, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Sana Biotechnology, Inc. (SANA): A Bull Case Theory - Insider Monkey
SANA SEC FilingsSana Biotechnology, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Sana Biotechnology (SANA) Stock Analysis: Exploring a Potential 104% Upside with Innovative Cell Therapies - DirectorsTalk Interviews
0.99%
3.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):